M. Karimi and V. De Sanctis, “Implications of SARSr-CoV 2 infection in thalassemias: Do patients fall into the ‘high clinical risk’ category?”, Acta Biomed, vol. 91, no. 2, pp. 50–56, May 2020, doi: 10.23750/abm.v91i2.9592.